A Rapid, Sensitive and Type-Specific Detection of High-Risk HPV-16 and HPV-18
- PMID: 37916056
- PMCID: PMC10616003
- DOI: 10.1007/s13224-023-01751-1
A Rapid, Sensitive and Type-Specific Detection of High-Risk HPV-16 and HPV-18
Abstract
Human papillomavirus (HPV) infection, particularly infection with HPVs 16 and 18, is a major cause of cervical cancer. The current high-risk HPV screening or diagnosis tests use cytological or molecular techniques that are primarily based on qualitative HPV DNA detection. Comparative studies, however, revealed that different assays have varying sensitivities for detecting specific HPV types. Here, we developed and optimized a sensitive PCR (Polymerase Chain Reaction) assay for detection of high-risk HPV-16 and HPV-18. The PCR parameters were optimized, and analytical specificities were validated. Performance of developed PCR assay was evaluated in clinical samples (n = 100) which showed 100% specificity for both the assays and 96.97% and 94.12% sensitivity for HPV-16 and HPV-18, respectively. The developed assay demonstrated high sensitivity and specificity for detection of high-risk HPV-16 and HPV-18, making it applicable to routine HPV detection practices.
Keywords: Cervical cancer; Detection; Human papillomavirus; PCR.
© Federation of Obstetric & Gynecological Societies of India 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestWe have no conflicts of interest to disclose.
Figures


Similar articles
-
Comparison of the clinical performances of the AdvanSure HPV Screening Real-Time PCR, the Abbott Real-Time High-Risk HPV Test, and the Hybrid Capture High-Risk HPV DNA Test for Cervical Cancer Screening.J Virol Methods. 2014 Sep 1;205:57-60. doi: 10.1016/j.jviromet.2014.04.021. Epub 2014 May 6. J Virol Methods. 2014. PMID: 24814874
-
Analytical performance evaluation of the HPV OncoCheck assay for detection of high-risk HPV infection in liquid-based cervical samples.Exp Mol Pathol. 2019 Feb;106:149-156. doi: 10.1016/j.yexmp.2018.12.008. Epub 2018 Dec 31. Exp Mol Pathol. 2019. PMID: 30605636
-
Head-to-Head Comparison of DH3 HPV Test and HC2 Assay for Detection of High-Risk HPV Infection in Residual Cytology Samples from Cervical Cancer Screening Setting: Baseline and 3-Year Longitudinal Data.Microbiol Spectr. 2022 Feb 23;10(1):e0157021. doi: 10.1128/spectrum.01570-21. Epub 2022 Feb 16. Microbiol Spectr. 2022. PMID: 35171029 Free PMC article.
-
The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studies.Acta Dermatovenerol Alp Pannonica Adriat. 2013;22(2):43-7. Acta Dermatovenerol Alp Pannonica Adriat. 2013. PMID: 23836358 Review.
-
Laboratory diagnosis of human papillomavirus infection.Curr Probl Dermatol. 2014;45:166-74. doi: 10.1159/000356515. Epub 2014 Mar 13. Curr Probl Dermatol. 2014. PMID: 24643185 Review.
Cited by
-
Analysis of Human Papillomavirus-Associated Cervical Cancer Differentially Expressed Genes and Identification of Prognostic Factors using Integrated Bioinformatics Approaches.Adv Biomed Res. 2024 Sep 23;13:78. doi: 10.4103/abr.abr_338_23. eCollection 2024. Adv Biomed Res. 2024. PMID: 39512411 Free PMC article.
References
LinkOut - more resources
Full Text Sources